Exagen Raises $5.3M For Diagnostic Tests
Albuquerque, New Mexico-baesd Exagen Diagnostics, which develops diagnostic testing for rheumatoid arthritis and other conditions, has raised $5.3M in a funding round. The round was led by Tullis Health Investors, and also included Sun Mountain Capital, Cottonwood Technology Fund, Mesa Verde Venture Partners and Epic Ventures. The firm said it will use the funding to finance market expansion and develop its near-term pipeline.
posted on Tuesday, September 11, 2012 (Link to more information)
Related companies:
Exagen Diagnostics
Related stories:
> Exagen Seeks FDA Nod on Breast Cancer Test Kit
> Exagen Diagnostics Names COO
> HealthTell Raises $26M For Diagnostics Testing
> Biodesix Raises $8.8M More
> Paradigm Diagnostics Finds $7M
Techrockies.com Home